AI assistant
Fulgent Genetics, Inc. — Director's Dealing 2022
Mar 2, 2022
32553_dirs_2022-03-02_768bf749-3579-47a7-8a37-4d129712b9d9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Fulgent Genetics, Inc. (FLGT)
CIK: 0001674930
Period of Report: 2022-02-28
Reporting Person: Gao Hanlin (Chief Scientific Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-02-28 | Common Stock | A | 9000 | $0.00 | Acquired | 824345 | Direct |
| 2022-02-28 | Common Stock | A | 32000 | $0.00 | Acquired | 856345 | Direct |
Footnotes
F1: Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after March 1, 2022, and 1/12th of such shares vesting at the end of every three-month period thereafter over the remaining 24 months, subject to continued service for Issuer on each vesting date.
F2: Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after March 1, 2022, and 1/16th of such shares vesting at the end of every three-month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date.